Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/10/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. James A. Lebovitz

Wrong James A. Lebovitz?

Partner

Phone: (215) ***-****  
Email: j***@***.com
Dechert LLP
2929 Arch Street Cira Centre
Philadelphia , Pennsylvania 19104
United States

Company Description: With more than 700 lawyers located in 15 cities around the world, Dechert LLP provides a full range of legal services to corporations and financial institutions in...   more
Background

Employment History

  • President of Board of Directors
    Fleisher Art Memorial
  • President of the Board of Trustees
    Samuel S. Fleisher Art Memorial

Board Memberships and Affiliations

Education

  • B.A.
    Yale College
  • J.D.
    University of Virginia School of Law
30 Total References
Web References
Fleisher - Board of Directors
www.fleisher.org, 5 Jan 2015 [cached]
James A. Lebovitz*
"We are honored to receive this ...
www.bartol.org, 1 Jan 2004 [cached]
"We are honored to receive this recognition and share this award with all of our community partners - children, adults, schools and community leaders," explained James Lebovitz, President of Fleisher's Board of Directors.
Dechert LLP : Lawyers
www.dechert-price.com, 17 June 2006 [cached]
James A. LebovitzDechert LLP : Lawyers
...
James A. Lebovitz
...
James A. LebovitzPartner
...
James A. Lebovitz is a partner and chair of the life sciences and technology group.He is also a member of the health law group.He has more than 20 years of experience focusing on corporate and securities law, with an emphasis on representation of both private and public life sciences, technology, and growth companies.He also has extensive experience representing venture capital investors and investment banking firms. ,, Mr. Lebovitz has particular experience representing companies in the life sciences industry, including pharmaceuticals, biotechnology, medical devices, and health care.He is recognized for his ability to capture and structure the capital life sciences companies need, including private placements and public offerings, to support the long development and commercialization process.In addition, he negotiates and executes strategic mergers, acquisitions, divestitures, spin-offs, joint ventures, and other strategic collaborations to enhance the development and commercialization of new technologies and scientific breakthroughs. ,, In the last few years alone, Mr. Lebovitz has advised on a wide range of domestic and international corporate finance and M&A transactions, including:,,
...
In addition, Mr. Lebovitz has been counsel to companies in the hardware, Internet, and credit card processing industries. ,, Mr. Lebovitz joined Dechert in July 1999 as a partner in the Philadelphia office following three years as the general counsel of a national, publicly traded, physician practice management company. ,, Professional Activities,Mr. Lebovitz is a Trustee of the Philadelphia Museum of Art and The Baldwin School and is President of the Board of Trustees of the Samuel S. Fleisher Art Memorial.
Education Mr. Lebovitz is a graduate of Yale College (B.A.,1979), where he served as editor-in-chief of the Yale Daily News, the University of Virginia School of Law (J.D., 1982), where he served as notes editor of The Virginia Journal of International Law, and the University of Cambridge (LL.M., 1983).
Dechert LLP : Lawyers
www.dechert.com, 29 Jan 2009 [cached]
James A. LebovitzDechert LLP : Lawyers
...
James A. Lebovitz
...
James A. LebovitzPartner
...
James A. Lebovitz is a partner in the corporate and securities and mergers and acquisitions groups.He focuses primarily on the representation of private and public life sciences, healthcare, technology, and growth companies and has extensive experience representing venture capital investors and investment banking firms.Mr. Lebovitz has been recognized as a leading lawyer for corporate/M&A and private equity by Chambers USA, a referral guide to leading lawyers in the United States.In its 2008 edition, Chambers noted that "he knows just how to get the deal done."Mr. Lebovitz is also recognized as a leading lawyer for corporate law, securities law, mergers and acquisitions law, leveraged buyouts and private equity law, and biotechnology law in The Best Lawyers in America and is listed for his extensive corporate finance experience in the 2007 and 2008 editions of The Legal 500 (U.S.), which notes that he is a "strong and experienced counselor."
, Mr. Lebovitz is recognized for his ability to capture and structure the capital life sciences companies need, including private placements and public offerings, to support the long development and commercialization process.He also negotiates and executes strategic mergers, acquisitions, divestitures, spin-offs, joint ventures, and other strategic collaborations to enhance the development and commercialization of new technologies and scientific breakthroughs.In addition, Mr. Lebovitz has experience advising companies in the technology, real estate, and business and financial services industries. ,, Mr. Lebovitz is the Chair of Dechert's firmwide lawyer hiring committee and previously served as partner responsible for associate development.From 2000 to 2005, he served as chair of the firm's business and technology practice group. ,, Mr. Lebovitz joined Dechert in July 1999 as a partner in the Philadelphia office following three years as the general counsel of a national, publicly traded, physician practice management company. ,, Professional Activities,Mr. Lebovitz is a former Trustee of the Philadelphia Museum of Art and of The Baldwin School and is a past President and current member of the Board of Trustees of the Samuel S. Fleisher Art Memorial.
Significant Representations In the last few years alone, Mr. Lebovitz has advised on a wide range of domestic and international corporate finance and M&A transactions, including: ,, -- JP Morgan in its role as: underwriter in the $86 million initial public offering of Emergent BioSolutions Inc.; initial purchaser in the $125 million offering of convertible notes and common stock by Oscient Pharmaceuticals Corporation; and placement agent in the $88 million public offering by Genome Therapeutics, $40 million offering by Altair Nanotechnologies, $31.9 million registered direct offering by Barrier Therapeutics, Inc., $30 million public offering by ArQule, Inc., $33.8 and $23.9 million public offerings by Neose Technologies, and $27.6 million offering by Bioenvision, Inc.,, -- Covance Inc., a leading clinical research organization (CRO) providing drug development services, in a $1.6 billion ten-year strategic alliance with Eli Lilly and Company,,
...
Mr. Lebovitz is a graduate of Yale College (B.A.,1979), where he served as editor-in-chief of the Yale Daily News, the University of Virginia School of Law (J.D., 1982), where he served as notes editor of The Virginia Journal of International Law, and the University of Cambridge (LL.M., 1983).
Board | The Mann Center
manncenter.org, 10 Jan 2015 [cached]
James A. Lebovitz Partner, Dechert, LLP
Other People with the name "Lebovitz":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304